In terms of subgroup analysis, KIF-12 showed significant expression differences in the T1 and T2 tumour stage subsets, M0 and N1 stage subsets, classical PTC, female population, BRAF mutation group, patients with unifocal neoplasm and patients aged ≤ 45 [Figure 2]. The gene discussed is KIF12; the disease is neoplasm.